Cargando…

Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression

Zhi-Zi-Hou-Po Decoction (ZZHPD) is a well-known traditional Chinese medicine (TCM) that has been widely used in depression. However, the antidepressant mechanism of ZZHPD has not yet been fully elucidated. The purpose of this study was to explore the pharmacological mechanisms of ZZHPD acting on dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yongtao, Zhang, Yingchun, Li, Shuolei, Zhang, Wenzhou, Wang, Xinhui, He, Baoxia, Ju, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531485/
https://www.ncbi.nlm.nih.gov/pubmed/34690756
http://dx.doi.org/10.3389/fphar.2021.711303
_version_ 1784586869347975168
author Bai, Yongtao
Zhang, Yingchun
Li, Shuolei
Zhang, Wenzhou
Wang, Xinhui
He, Baoxia
Ju, Wenzheng
author_facet Bai, Yongtao
Zhang, Yingchun
Li, Shuolei
Zhang, Wenzhou
Wang, Xinhui
He, Baoxia
Ju, Wenzheng
author_sort Bai, Yongtao
collection PubMed
description Zhi-Zi-Hou-Po Decoction (ZZHPD) is a well-known traditional Chinese medicine (TCM) that has been widely used in depression. However, the antidepressant mechanism of ZZHPD has not yet been fully elucidated. The purpose of this study was to explore the pharmacological mechanisms of ZZHPD acting on depression by combining ultra flow liquid chromatography with quadrupole time-of-flight mass spectrometry (UFLC-Q-TOF/MS) and network pharmacology strategy. The chemical components of ZZHPD were identified using UFLC-Q-TOF/MS, while the potential drug targets and depression-related targets were collected from databases on the basis of the identified compounds of ZZHPD. Protein-protein interaction (PPI) network, gene ontology (GO), and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses were used to unravel potential antidepressant mechanisms. The predicted antidepressant targets from the pharmacology-based analysis were further verified in vivo. As a result, a total of 31 chemical compounds were identified by UFLC-Q-TOF/MS; 514 promising drug targets were mined by using the Swiss Target Prediction; and 527 depression-related target genes were pinpointed by the GeneCards and OMIM databases. STRING database and Cytoscape’s topological analysis revealed 80 potential targets related to the antidepressant mechanism of ZZHPD. The KEGG pathway analysis revealed that the antidepressant targets of ZZHPD were mainly involved in dopaminergic synapse, serotonin synapse, cAMP, and mTOR signaling pathways. Furthermore, based on the animal model of depression induced by chronic corticosterone, the regulatory effects of ZZHPD on the expression of MAOA, MAOB, DRD2, CREBBP, AKT1, MAPK1, HTR1A, and GRIN2B mRNA levels as well as the cAMP signaling pathway and monoaminergic metabolism were experimentally verified in rats. Our study revealed that ZZHPD is expounded to target various genes and pathways to perform its antidepressant effect.
format Online
Article
Text
id pubmed-8531485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85314852021-10-23 Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression Bai, Yongtao Zhang, Yingchun Li, Shuolei Zhang, Wenzhou Wang, Xinhui He, Baoxia Ju, Wenzheng Front Pharmacol Pharmacology Zhi-Zi-Hou-Po Decoction (ZZHPD) is a well-known traditional Chinese medicine (TCM) that has been widely used in depression. However, the antidepressant mechanism of ZZHPD has not yet been fully elucidated. The purpose of this study was to explore the pharmacological mechanisms of ZZHPD acting on depression by combining ultra flow liquid chromatography with quadrupole time-of-flight mass spectrometry (UFLC-Q-TOF/MS) and network pharmacology strategy. The chemical components of ZZHPD were identified using UFLC-Q-TOF/MS, while the potential drug targets and depression-related targets were collected from databases on the basis of the identified compounds of ZZHPD. Protein-protein interaction (PPI) network, gene ontology (GO), and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses were used to unravel potential antidepressant mechanisms. The predicted antidepressant targets from the pharmacology-based analysis were further verified in vivo. As a result, a total of 31 chemical compounds were identified by UFLC-Q-TOF/MS; 514 promising drug targets were mined by using the Swiss Target Prediction; and 527 depression-related target genes were pinpointed by the GeneCards and OMIM databases. STRING database and Cytoscape’s topological analysis revealed 80 potential targets related to the antidepressant mechanism of ZZHPD. The KEGG pathway analysis revealed that the antidepressant targets of ZZHPD were mainly involved in dopaminergic synapse, serotonin synapse, cAMP, and mTOR signaling pathways. Furthermore, based on the animal model of depression induced by chronic corticosterone, the regulatory effects of ZZHPD on the expression of MAOA, MAOB, DRD2, CREBBP, AKT1, MAPK1, HTR1A, and GRIN2B mRNA levels as well as the cAMP signaling pathway and monoaminergic metabolism were experimentally verified in rats. Our study revealed that ZZHPD is expounded to target various genes and pathways to perform its antidepressant effect. Frontiers Media S.A. 2021-10-08 /pmc/articles/PMC8531485/ /pubmed/34690756 http://dx.doi.org/10.3389/fphar.2021.711303 Text en Copyright © 2021 Bai, Zhang, Li, Zhang, Wang, He and Ju. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bai, Yongtao
Zhang, Yingchun
Li, Shuolei
Zhang, Wenzhou
Wang, Xinhui
He, Baoxia
Ju, Wenzheng
Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title_full Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title_fullStr Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title_full_unstemmed Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title_short Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Zhi-Zi-Hou-Po Decoction in Depression
title_sort integrated network pharmacology analysis and experimental validation to investigate the mechanism of zhi-zi-hou-po decoction in depression
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531485/
https://www.ncbi.nlm.nih.gov/pubmed/34690756
http://dx.doi.org/10.3389/fphar.2021.711303
work_keys_str_mv AT baiyongtao integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT zhangyingchun integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT lishuolei integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT zhangwenzhou integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT wangxinhui integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT hebaoxia integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression
AT juwenzheng integratednetworkpharmacologyanalysisandexperimentalvalidationtoinvestigatethemechanismofzhizihoupodecoctionindepression